The prevalence of frailty and its association with clinical outcomes in general surgery: a systematic review and meta-analysis by Hewitt, Jonathan et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/114585/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Hewitt, Jonathan, Long, Sara, Carter, Ben, Bach, Simon, McCarthy, Kathryn and Clegg, Andrew
2018. The prevalence of frailty and its association with clinical outcomes in general surgery: a
systematic review and meta-analysis. Age and Ageing 47 (6) , pp. 793-800. 10.1093/ageing/afy110
file 
Publishers page: http://dx.doi.org/10.1093/ageing/afy110 <http://dx.doi.org/10.1093/ageing/afy110>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
The Prevalence of Frailty and its association with clinical outcomes in General 
Surgery: A Systematic Review and Meta-Analysis. 
 
ABSTRACT 
 
OBJECTIVES: To investigate the prevalence and impact of frailty for general 
surgical patients. 
RESEARCH DESIGN AND METHODS: We conducted a systematic review and 
meta-analysis. Studies published between January 1980 and  August 31st  2017 
were searched from 7 databases. Incidence of clinical outcomes (mortality at day 30 
and day 90; readmission at day 30; and surgical complication) were estimated for 
patients categorized into frailty subgroup (not-frail, pre-frail, and frail). Both 
emergency and elective studies were included. 
RESULTS: 2281 participants from 9 studies were included, 49.3% (1013/2055) were 
male. Mean age ranged from 61 to 77 years old. The prevalence estimate of frailty 
ranged between 31.3%-45.8% for pre-frailty and 10.4%-37% for frailty. After pooling, 
day 30 mortality was 8% (95% CI 4 to 12%; I2=0%) for frail compared to 1% for non-
frail patients (95% CI 0 to 2%; I2=75%).  Due to heterogeneity the day 90 mortality 
was not pooled. Re-admission rates were 18% (95% CI 11 to 24%; I2 = 75%) in the 
frail and 11% (95% CI 7 to 14%; I2=78%) in the non frail. Complications in the frail 
patients was 24%, (95% CI 20 to 31%;I2=92% and in the pre-frail subgroup  9% 
(95% CI 5 to 14%; I2=82%)  5% (95% CI 3 to 7%; I2=70%) in the non frail. The mean 
length of stay in frail people was 9.57 days (95% CI 6.24 to 12.90) and 6.44 days 
(4.91 to 7.92) in the non frail,  
CONCLUSIONS: Frailty is associated with adverse post-operative outcomes in both 
emergency and elective general surgery. 
 
 
 
Background 
 
Frailty is a condition characterised by loss of biological reserves, failure of homeostatic 
mechanisms and vulnerability to adverse outcomes following stressor events such as 
surgery. Delivery of surgical care becomes more challenging in this context (1). Faced 
with an ageing population whose rate of general surgical intervention is increasing 
rapidly, awareness of frailty is becoming more widespread in surgical and critical care 
settings(2). Similarly, the importance of the identification and management of the frail 
patient is increasingly being recognized(3). A modest but increasing number of studies 
have recently assessed a number of different frailty tools in both emergency and 
elective general surgery against a range of outcomes. However, no systematic reviews 
have yet attempted to give an overview of their use.  
 
The aim of this review was to assess frailty prevalence and its association with clinical 
outcomes across general surgical specialties. 
 
Methods 
This study was carried out following PRISMA guidelines. The review was registered 
and the protocol is available on Research Registry (reviewregistry129, 
http://www.researchregistry.com) 
 
Search strategy 
We searched seven  electronic databases (Medline, CINAHL, The Cochrane Library, 
AMED, PSYCINFO, EMBASE and Web of Science) for manuscripts published from 
January 1st, 1946, to August 31st, 2017. All identified and relevant studies’ references 
were manually reviewed to identify any potential studies that apply or support the study 
hypothesis. The search terms were based on MeSH terms (Medical Subject Headings) 
and other controlled vocabulary.  Search terms relating to surgery, frailty and risk 
factors were used.  The search strategy is outlined in supplementary file 1.   
 
Eligibility criteria and study identification 
The review process is summarised in a PRISMA flow diagram (Figure 1). 
Randomized controlled trials; cohort studies; and case-control study designs were 
eligible for inclusion. Only studies using a validated method of frailty identification were 
included(3). Studies that used large scale database analysis assessing frailty and 
surgery were excluded(4). Studies based solely in intensive care were excluded since 
these populations are atypical and could introduce additional confounders. No 
language restrictions were applied 
 Two reviewers (JH, SL) searched the literature and assessed the studies for eligibility 
independently; disagreements were resolved through discussion with a third reviewer 
(BC).  
 
Data extraction and quality assessment  
Demographic information, frailty tool, frailty prevalence and outcomes data were 
extracted from the included studies independently by two reviewers (JH, SL) 
disagreements were resolved through discussion with a third reviewer (BC). 
Study authors were contacted to clarify or provide additional data where it was missing 
or unclear. 
For the studies included the quality assessment was conducted by two reviewers 
independently (JH, SL) and arbitrated by a third (BC) using the Newcastle-Ottawa 
Scale (NOS)(5), which assesses the risk of bias of observational studies. Scores were 
assigned for selection criteria, comparability and outcome. Each domain examined 
was determined as of acceptable quality, unclear or not acceptable. A maximum score 
of 9 reflects highest quality. If a study was scored 7-9, it was categorized as a good 
study, 4-6 as fair quality and 0-3 as poor quality.  
 
Data analysis 
Frailty prevalence was estimated using studies that had categorized frailty using 
standard specific cut-offs for validated frailty tools (6-10) For consistency, prevalence 
was not calculated using studies where participants were defined as being frail using 
a non-standard cut-off. 
 
Data were extracted for the following primary outcomes: short term mortality (30 day), 
and medium term (3 to 6 months) term mortality. Further data were extracted for the 
following secondary outcomes: 30 day readmission to hospital, complications and 
length of hospital stay. All outcomes captured dichotomous data except for the length 
of stay, and the treatment effects were measured by the proportion of patients 
experiencing the outcome. Continuous data for the length of stay were skewed, so 
were transformed and summary statistics were calculated on the transformed scale. 
Frailty subgroups were used to explore the association between frailty and outcomes. 
If study design and population did not exhibit clinical heterogeneity, data were pooled 
in a random effects meta-analysis. All the meta-analysis was conducted using Stata 
version 13.0.  
 
Assessment of subgroups and statistical heterogeneity 
Heterogeneity was assessed using the I2 statistic, and pooling that exhibited an I2 over 
85% was explored using subgroup analyses. All meta-analyses were presented as an 
estimated proportion, associated 95% confidence (95% CI), P-values and I2 summary 
data. Frailty was a pre-specified subgroup to explore the association between frailty 
and outcomes. Patients were categorized as non-frail, pre-frail or frail. The following 
pre-specified subgroups were used to explain heterogeneity: quality assessment (high 
quality, versus unclear and low quality studies); age of patients (65 to 70; 70 to 80; 
80+); type of surgery (elective; emergency; or combined). 
 
Results 
Identified studies and quality assessment 
After removal of duplicates, 5994 records were identified, and led to 21 full texts being 
reviewed, where 12 were excluded. Nine were included in this analysis and are shown 
in the PRISMA diagram (Figure 1)(11-19). One study only considered frailty 
prevalence (11). This study was not considered in the meta-analysis or the quality 
assessment (Supplementary Table 1). Five studies were determined as good 
quality(12, 13, 15, 17, 20), three were categorized as fair quality(14, 16, 19) and none 
were categorized as poor quality. The average NOS score was 8.3. For further details 
of the results of the quality assessment tool, see Supplementary Figure 1. 
  
Figure 1: PRISMA Flowchart of included studies  
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Characteristics of the included studies 
From the 9 studies 2281 patients were included, 49.3% were male (1013/2055) and 
six studies only recruited older patients (over 65 year olds), the mean age ranged from 
61 to 77 years old (Supplementary Table 1). 
Frailty Prevalence 
The 9 included studies used a range of frailty assessment tools, of which seven were 
deemed suitable for inclusion in the prevalence estimation. One study(17) 
oversampled complex cases, as such it was not a representative sample to be 
included in the prevalence data. The other excluded study used a range of frailty 
scales and was not suitable for inclusion(14). Of the included studies, two used the 
phenotype model(11, 15)), two the Groningen Frailty Indicator (16, 20), two the deficit 
based model (12, 13) and one a seven point assessment of frailty traits (9). The 
prevalence of pre-frail ranged between 31.3%-45.8%, frailty prevalence ranged 
between 10.4%-37%. The included studies and the prevalence estimated are shown 
in Supplementary Table 2. 
Primary outcome:  
Short term mortality (Day 30), and medium term mortality (Day 90 to Day 180).  
Three studies reported mortality at Day 30 (12, 13, 16), this included 9% (17/192) 
patients who were determined as frail, and 3% (12/479) who were not frail. After 
pooling the proportion who were frail was 8% (95% CI 4 to 12%; I2=0%), which 
compared to 1% who were not frail (95% CI 0 to 2%; I2=75%, Figure 2).  
Two studies reported mortality in the medium term (12, 18), 23% (24/105) died who 
were frail, compared to 11% (34/300) who were not frail. After pooling the proportion 
who died that were frail was 17% (95% CI 11 to 24%; I2=39%), compared to 7% who 
were not frail (95% CI 4 to 10%; I2=93%; Figure 3). The pooled exhibited severe 
heterogeneity, and may be unreliable so are not included within Figure 3. 
 
Secondary outcomes:  
Readmission at Day 30 
Two studies reported the proportion of patients with a re-admission(12, 19) The 
proportion who were re-admitted in those that were frail was 18% (95% CI 11 to 24%; 
I2 = 75%) and 11% (95% CI 7 to 14%; I2=78%) in those that were not frail, see 
Supplementary Figure 1. 
Surgical Complications  
Four Studies reported the proportion of patients who suffered surgical complications 
(13, 15, 16, 19). Severe clinical heterogeneity was exhibited between the studies, 
which was explained in part by frailty. The estimated proportion to exhibit complications 
from the frail subgroup of patients was 24%, (95% CI 20 to 31%;I2=92%, Figure 4) pre-
frail subgroup  9% (95% CI 5 to 14%; I2=82%); and from the not-frail subgroup  5% 
(95% CI 3 to 7%; I2=70%). Post operative complications were  assessed using a 
variety of tools, including the Accordion Severity Classification(19), the American 
College of Surgeons National Surgical Improvement Program definitions(13, 15) and 
those constructed directly by the study authors(16). 
Length of Stay 
Four studies presented data on the length of stay and applied cut offs for participants 
as either frail, or non-frail (9, 12, 13, 20). The pooled mean length of stay in frail people 
was 9.57 days (95% CI 6.24 to 12.90) and in those who were non-frail was 6.44 days 
(4.91 to 7.92), see Supplementary Figure 2. However, substantial heterogeneity that 
could not be explained was found within both of these subgroups so caution is needed 
when interpreting these findings.   
Due to the few numbers of included studies no sensitivity analyses were carried out.  
Discussion  
This study identified 9 studies, of which 8 were included in the analyses and were 
quality assessed. Six studied elective and three considered emergency surgical 
patients. The studies covered a wide range of upper and lower abdominal surgical 
conditions, including both benign and malignant conditions, five of which were good 
quality and the remaining three fair quality.   
We found clear evidence of an increase in the proportion of patients that suffered 
mortality and surgical complications in those that were frail, compared to those 
patients who were not frail. Pooled analysis identified short term (up to 30 day) and 
medium term (up to 180 day) mortality to be more frequent in those people who were 
frail. Post-operative complications and readmission to hospital within 30 days of 
discharge were also more frequent in frail individuals following their surgical illness. 
This review is the first review to characterize frailty in a general surgery patient group. 
Other recent reviews, whilst also demonstrating that frailty was associated with post-
operative complications examined studies from a range of surgical specialties, not 
solely general surgery, for example Lin and colleagues(21) and the narrative review 
by Beggs etal (22). This review also differs as it considers eight trials for meta-analysis. 
Lin etal identified three general surgical articles for review but did not perform meta-
analysis. Of the three studies which were considered by those authors, two (12, 14) 
are considered in this review and one(23) was excluded because of the frailty 
assessment tool used was constructed by the study authors. 
 
Strengths and weaknesses  
In general, all of the studies included were of at least moderate quality, with more than 
half being judged as good quality, as reflected by the minimum Newcastle-Ottawa-
Scale (NOS) result being 6, with an average score of 8.3.  
 
Due to the non-randomised nature of the included studies a combination of: selection 
bias; performance bias; confounding and reporting bias is possible so the findings of 
this review should be viewed with caution and with a high risk of bias. However, the 
strength of evidence linking frailty to poorer outcomes is consistent, with little evidence 
of heterogeneity in most outcomes, and clearly different for the frailty subgroup, with 
a dose-response of poorer outcomes linked to frail, compared with the pre-frail 
subgroup, although the pre frail group was comprised of a comparatively small number 
of participants. The biological plausibility and a reasonable consistency across the 
varying studies is indicative that frailty is linked with poorer post-surgical outcomes.  
There was heterogeneity found within the post operative complications outcomes, but 
we believe that this was introduced by differing methods used to assess post operative 
complications. For example two studies(13, 15) used the  American College of Surgery 
national Surgical Quality Improvement Program definition, one(9) the American 
Society Guidelines and another(16) defined their own list of post operative 
complications to be recorded. Future studies should consider using a standardized 
post operative complication definition, as this will aid accurate comparison between 
frail surgical patients across studies. 
The quantity of robust published data for individual outcomes was limited. None of the 
preselected outcome measures were reported in more than four studies and two 
(medium term mortality and readmission to hospital) were only reported in two studies. 
Using small numbers of studies for meta-analysis requires a degree of caution when 
interpreting results, but throughout all of the outcomes there is a consistent and 
repeated effect of frailty.   
 
A potential limitation was the absence of data from patients with special clinical 
situations such as intensive care admission. The decision was taken to exclude these 
data to avoid introducing confounding. However, it should be noted as a potential area 
for future dedicated systematic review in light of evidence that frailty predicts risk of 
institutionalization in surgical patients who are admitted to intensive care(9)   
 
The present review found a range of frailty assessment tools were chosen and 
implemented across the studies which will have introduced heterogeneity. This is to 
be expected as there are two broad models used for frailty assessment, the phenotype 
model and the accumulation of deficits model. Both models are valid and can be 
applied to research and clinical situations with the proviso that staff using these tools 
are trained in their use(24).  The search criteria in this review stated that we would 
only include studies that employed recognized frailty assessment methods. Eight of 
the included studies used either phenotype or deficit accumulation models. The only 
caution and deviation from the inclusion criteria was the decision to include the study 
by Robinson etal(9). This study did not use an established frailty assessment tool 
which conformed to either of the models described above. However, the primary 
author and the associated team have published widely in the field of surgical disease 
in the older person and the assessment tool they use is robust, validated and is being 
used by additional research groups. Therefore, following consensus, it was decided to 
include this study.  
  
It is also of note that one study (18) met our inclusion criteria but did not form part of 
the analysis. It was not possible to extract data from those contained in the manuscript. 
No response was received from the study authors for a more detailed breakdown of 
data which may have been usable. Should future studies wish to revisit this area, 
perhaps to address a different outcome, these data need to be included for 
completeness. The findings of the study were all in keeping with the reported meta-
analysis and frailty showed an association with morbidity (p=0.02). 
 
Additionally we excluded large database type assessments of frailty(4) from our 
analysis. The primary rationale was three fold. Firstly  these studies used frailty 
assessments derived specifically for each database according to the factors available 
within them and were not uniform in construction. Secondly, they were of such scale 
that to have included them would have influenced the results to such an extent that 
other smaller studies would have had virtually no effect on the outcome measures 
generated and thirdly none of them used assessments that are used in clinical 
practice, limiting their day to day utility.  
 
Implications for research and clinical practice 
All of the included studies were published since 2010, and it is likely that further studies 
will be suitable for combination with the data shown here to further reinforce (or 
repudiate) our findings. Perhaps more importantly, it is likely that additional outcome 
data will become available for measures such as long term mortality, and for patient-
facing measures such as quality of life after surgery and requirement for social care 
provision. Further research in these areas will allow more comprehensive assessment 
of the impact that surgical conditions and their management have on frail patients.  
  
By establishing the impact of frailty on both morbidity and mortality, this study further 
highlights the importance of this clinical condition. Clinicians can use the presence of 
frailty to predict worse outcomes in general surgery irrespective of age. Where 
possible frailty should be identified pre-operatively, allowing the use of targeted 
interventions such as Comprehensive Geriatric Assessment(25, 26) with the aim of 
optimizing clinical condition prior to surgical management.  
Conclusions  
This study demonstrated that frailty is common in both elective and emergency general 
surgery. Despite a limited number of studies included in each of the meta-analyses 
frailty demonstrated a consistent association with both mortality and morbidity.  
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Figure 3 Mortality at Day 90 to 180  
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frailty and type of procedure (elective or emergency) 
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